{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:46:10Z","timestamp":1795020370431,"version":"4.10.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Emerg Med"],"DOI":"10.1186\/s12245-025-00951-y","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T13:35:37Z","timestamp":1754055337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effectiveness and safety of vernakalant vs flecainide for cardioversion of atrial fibrillation in the emergency department: the VERITA study"],"prefix":"10.1186","volume":"18","author":[{"given":"Giuseppe","family":"Dominijanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio F.","family":"Caballero-Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sainz-Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Pineda-Torcuato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Capilla-Pueyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Ruiz-Antor\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"1","key":"951_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1\u2013156. https:\/\/doi.org\/10.1161\/CIR.0000000000001193.","journal-title":"Circulation"},{"key":"951_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ajem.2021.07.055","volume":"50","author":"M Varona","year":"2021","unstructured":"Varona M, Coll-Vinent B, Mart\u00edn A, et al. Factors associated with poor prognosis in patients with atrial fibrillation: an emergency department perspective the EMERG-AF study. Am J Emerg Med. 2021;50:270\u20137. https:\/\/doi.org\/10.1016\/j.ajem.2021.07.055.","journal-title":"Am J Emerg Med"},{"issue":"14","key":"951_CR3","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/eurheartj\/eht044","volume":"34","author":"DP Leong","year":"2013","unstructured":"Leong DP, Eikelboom JW, Healey JS, Connolly SJ. Atrial fibrillation is associated with increased mortality: causation or association? Eur Heart J. 2013;34(14):1027\u201330. https:\/\/doi.org\/10.1093\/eurheartj\/eht044.","journal-title":"Eur Heart J"},{"issue":"3","key":"951_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/01.cir.104.3.292","volume":"104","author":"OD Pedersen","year":"2001","unstructured":"Pedersen OD, Bagger H, Keller N, Marchant B, K\u00f8ber L, Torp-Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation. 2001;104(3):292\u20136. https:\/\/doi.org\/10.1161\/01.cir.104.3.292.","journal-title":"Circulation"},{"issue":"12","key":"951_CR5","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","volume":"109","author":"SD Corley","year":"2004","unstructured":"Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004;109(12):1509\u201313. https:\/\/doi.org\/10.1161\/01.CIR.0000121736.16643.11.","journal-title":"Circulation"},{"key":"951_CR6","doi-asserted-by":"publisher","unstructured":"Miota Hern\u00e1ndez N, Canadell Marcos N, Garc\u00eda-Mart\u00ednez A, et al. Safety and efficacy of electric cardioversion in the emergency department: analysis of associated factors according to gender. Emergencias. 2024. https:\/\/doi.org\/10.55633\/s3me\/050.2024.","DOI":"10.55633\/s3me\/050.2024"},{"issue":"5","key":"951_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","journal-title":"Eur Heart J"},{"key":"951_CR8","unstructured":"Carbajosa Dalmau J, Cos\u00edn-Sales J, P\u00e9rez-Dur\u00e1 MJ, et al. Vernakalant in hospital emergency practice: safety and effectiveness. Emergencias Rev la Soc Esp Med Emergencias. 29(6):397\u2013402. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29188914."},{"issue":"2","key":"951_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10557-020-07127-1","volume":"35","author":"D Tsiachris","year":"2021","unstructured":"Tsiachris D, Doundoulakis I, Pagkalidou E, et al. Pharmacologic cardioversion in patients with paroxysmal atrial fibrillation: a network meta-analysis. Cardiovasc Drugs Ther. 2021;35(2):293\u2013308. https:\/\/doi.org\/10.1007\/s10557-020-07127-1.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"8","key":"951_CR10","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.ajem.2016.05.012","volume":"34","author":"R Kriz","year":"2016","unstructured":"Kriz R, Freynhofer MK, Weiss TW, et al. Safety and efficacy of pharmacological cardioversion of recent-onset atrial fibrillation: a single-center experience. Am J Emerg Med. 2016;34(8):1486\u201390. https:\/\/doi.org\/10.1016\/j.ajem.2016.05.012.","journal-title":"Am J Emerg Med"},{"issue":"6","key":"951_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1517\/14656566.2014.898751","volume":"15","author":"RA Brown","year":"2014","unstructured":"Brown RA, Lau YC, Lip GYH. Vernakalant hydrochloride to treat atrial fibrillation. Expert Opin Pharmacother. 2014;15(6):865\u201372. https:\/\/doi.org\/10.1517\/14656566.2014.898751.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"951_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/2048872617728558","volume":"8","author":"H Pohjant\u00e4hti-Maaroos","year":"2019","unstructured":"Pohjant\u00e4hti-Maaroos H, Hypp\u00f6l\u00e4 H, Lekkala M, Sinisalo E, Heikkola A, Hartikainen J. Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation. Eur Hear journal Acute Cardiovasc care. 2019;8(2):114\u201320. https:\/\/doi.org\/10.1177\/2048872617728558.","journal-title":"Eur Hear journal Acute Cardiovasc care"},{"issue":"3","key":"951_CR13","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.ijcard.2013.02.006","volume":"168","author":"D Conde","year":"2013","unstructured":"Conde D, Costabel JP, Caro M, et al. Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation. Int J Cardiol. 2013;168(3):2423\u20135. https:\/\/doi.org\/10.1016\/j.ijcard.2013.02.006.","journal-title":"Int J Cardiol"},{"issue":"10","key":"951_CR14","doi-asserted-by":"publisher","first-page":"1330.e13","DOI":"10.1016\/j.cjca.2013.01.002","volume":"29","author":"D Conde","year":"2013","unstructured":"Conde D, Costabel JP, Aragon M, et al. Flecainide or propafenone vs. vernakalant for conversion of recent-onset atrial fibrillation. Can J Cardiol. 2013;29(10):1330.e13. https:\/\/doi.org\/10.1016\/j.cjca.2013.01.002.","journal-title":"Can J Cardiol."},{"issue":"1","key":"951_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/14017431.2012.740572","volume":"47","author":"M Heldal","year":"2013","unstructured":"Heldal M, Atar D. Pharmacological conversion of recent-onset atrial fibrillation: a systematic review. Scand Cardiovasc J Suppl. 2013;47(1):2\u201310. https:\/\/doi.org\/10.3109\/14017431.2012.740572.","journal-title":"Scand Cardiovasc J Suppl"},{"issue":"4","key":"951_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/europace\/eun048","volume":"10","author":"A Ringborg","year":"2008","unstructured":"Ringborg A, Nieuwlaat R, Lindgren P, et al. Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace. 2008;10(4):403\u201311. https:\/\/doi.org\/10.1093\/europace\/eun048.","journal-title":"Europace"},{"issue":"2","key":"951_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10557-012-6374-4","volume":"26","author":"LD Bash","year":"2012","unstructured":"Bash LD, Buono JL, Davies GM, et al. Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation. Cardiovasc drugs Ther. 2012;26(2):167\u201379. https:\/\/doi.org\/10.1007\/s10557-012-6374-4.","journal-title":"Cardiovasc drugs Ther"},{"key":"951_CR18","doi-asserted-by":"publisher","unstructured":"deSouza IS, Shrestha P, Allen R, Koos J, Thode H. Safety and effectiveness of antidysrhythmic drugs for pharmacologic cardioversion of recent-onset atrial fibrillation: a systematic review and Bayesian network meta-analysis. Cardiovasc Drugs Ther. 2024. https:\/\/doi.org\/10.1007\/s10557-024-07552-6.","DOI":"10.1007\/s10557-024-07552-6"}],"container-title":["International Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-025-00951-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12245-025-00951-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-025-00951-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T02:14:07Z","timestamp":1754360047000},"score":1,"resource":{"primary":{"URL":"https:\/\/intjem.biomedcentral.com\/articles\/10.1186\/s12245-025-00951-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["951"],"URL":"https:\/\/doi.org\/10.1186\/s12245-025-00951-y","relation":{},"ISSN":["1865-1380"],"issn-type":[{"value":"1865-1380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Hospital Universitario Puerta de Hierro\u2019s Research Ethics Committee (REC) (PI 73\/22) and conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. The study was granted a waiver of informed consent by the REC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}